Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-02-11 5:49 pm Sale | 2021-12-31 | 13G | Lexaria Bioscience Corp. LEXX | L1 Capital Global Opportunities Master Fund, Ltd. | 159,000 2.600% | -126,714![]() (-44.35%) | Filing History |
2022-02-11 5:49 pm Sale | 2021-12-31 | 13G | Seanergy Maritime Holdings Corp. SHIP | L1 Capital Global Opportunities Master Fund, Ltd. | 25,000 0.001% | -21,875![]() (-46.67%) | Filing History |
2022-02-11 5:48 pm Sale | 2021-12-31 | 13G | Titan Pharmaceuticals, Inc. TTNP | L1 Capital Global Opportunities Master Fund, Ltd. | 24,736 4.990% | -9,327![]() (-27.38%) | Filing History |
2022-02-11 5:48 pm Sale | 2021-12-31 | 13G | GeoVax Labs, Inc. GOVX | L1 Capital Global Opportunities Master Fund, Ltd. | 0 0.000% | -25,597![]() (Position Closed) | Filing History |
2022-02-11 5:47 pm Sale | 2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX | L1 Capital Global Opportunities Master Fund, Ltd. | 7,000 11.000% | -59,667![]() (-89.50%) | Filing History |
2021-12-08 5:00 pm Purchase | 2021-12-07 | 13G | Creative Medical Technology Holdings, Inc. CELZ | L1 Capital Global Opportunities Master Fund, Ltd. | 32,746 5.100% | 32,746![]() (New Position) | Filing History |
2021-11-18 4:30 pm Purchase | 2021-07-02 | 13G | Recruiter.com Group, Inc. RCRT | L1 Capital Global Opportunities Master Fund, Ltd. | 70,195 7.300% | 70,195![]() (New Position) | Filing History |
2021-03-05 4:13 pm Purchase | 2021-02-26 | 13G | BriaCell Therapeutics Corp. BCTX | L1 Capital Global Opportunities Master Fund, Ltd. | 66,667 16.300% | 66,667![]() (New Position) | Filing History |
2021-02-09 4:46 pm Sale | 2020-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | L1 Capital Global Opportunities Master Fund, Ltd. | 42,450 4.800% | -42,450![]() (-50.00%) | Filing History |
2021-02-09 4:45 pm Purchase | 2020-12-31 | 13G | Recon Technology, Ltd. RCON | L1 Capital Global Opportunities Master Fund, Ltd. | 12,222 3.000% | 1,667![]() (+15.79%) | Filing History |
2021-02-09 4:44 pm Sale | 2020-12-31 | 13G | URBAN TEA INC USD MYT | L1 Capital Global Opportunities Master Fund, Ltd. | 0 0.000% | -6,250,000![]() (Position Closed) | Filing History |
2021-02-09 4:43 pm Purchase | 2020-12-31 | 13G | Globus Maritime Limited GLBS | L1 Capital Global Opportunities Master Fund, Ltd. | 158,500 4.800% | 138,149![]() (+678.82%) | Filing History |
2021-02-09 4:08 pm Sale | 2020-12-31 | 13G | LM Funding America, Inc. LMFA | L1 Capital Global Opportunities Master Fund, Ltd. | 31,833 3.500% | -20,433![]() (-39.09%) | Filing History |
2021-01-25 08:26 am Purchase | 2021-01-15 | 13G | Titan Pharmaceuticals, Inc. TTNP | L1 Capital Global Opportunities Master Fund, Ltd. | 34,063 6.900% | 17,863![]() (+110.26%) | Filing History |
2021-01-20 4:05 pm Purchase | 2021-01-12 | 13G | Lexaria Bioscience Corp. LEXX | L1 Capital Global Opportunities Master Fund, Ltd. | 285,714 5.600% | 285,714![]() (New Position) | Filing History |
2021-01-19 08:31 am Purchase | 2021-01-06 | 13G | American International Holdings Corp. AMIH | L1 Capital Global Opportunities Master Fund, Ltd. | 74,583 7.500% | 74,583![]() (New Position) | Filing History |
2020-11-02 4:10 pm Purchase | 2020-10-22 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | L1 Capital Global Opportunities Master Fund, Ltd. | 84,900 8.600% | 84,900![]() (New Position) | Filing History |
2020-10-01 4:41 pm Purchase | 2020-09-24 | 13G | Titan Pharmaceuticals, Inc. TTNP | L1 Capital Global Opportunities Master Fund, Ltd. | 16,200 8.300% | 16,200![]() (New Position) | Filing History |
2020-09-30 4:05 pm Purchase | 2020-09-25 | 13G | GeoVax Labs, Inc. GOVX | L1 Capital Global Opportunities Master Fund, Ltd. | 25,597 9.900% | 25,597![]() (New Position) | Filing History |
2020-08-24 4:26 pm Purchase | 2020-08-14 | 13G | LM Funding America, Inc. LMFA | L1 Capital Global Opportunities Master Fund, Ltd. | 52,267 9.900% | 52,267![]() (New Position) | Filing History |